The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma.

Letizia ProcaccioValeria MerzMorena FasanoVanja VaccaroElisa GiommoniAndrea PrettaSilvia NoventaMaria Antonietta SatolliGuido GiordanoClizia ZichiCarmine PintoCamilla ZecchettoGiulia BarsottiFerdinando De VitaMichele MilellaLorenzo AntonuzzoMario ScartozziAlberto ZaniboniRosella SpadiSimona CasalinoFrancesca BergamoChiara De ToniDavide MelisiSara Lonardi

Published in: Cancer medicine (2023)

These real-world data confirm the 5-FU/LV-nal-IRI efficacy and safety in advPDAC patients progressed to gemcitabine-based therapy, with outcomes comparable to NAPOLI-1, even in a less-selected population and with more modern therapeutic algorithm.

Keyphrases

end stage renal disease
chronic kidney disease
healthcare
newly diagnosed
ejection fraction
machine learning
prognostic factors
deep learning
palliative care
stem cells
electronic health record
metabolic syndrome
chronic pain
squamous cell carcinoma
locally advanced
rectal cancer
cell therapy